Genentech - PDFSEARCH.IO - Document Search Engine

Genentech
Results: 384

#	Item
351	Genentech Sustainability Data and Notes[removed]Performance Data Units 2008 Add to Reading List Source URL: www.gene.com Language: English - Date: 2014-03-31 07:24:03 Air dispersion modeling Electric power Greenhouse gas emissions Emission intensity AP 42 Compilation of Air Pollutant Emission Factors Emissions & Generation Resource Integrated Database Greenhouse gas inventory Emission standard Greenhouse gas Air pollution Atmosphere Pollution
352	1 DNA Way South San Francisco, CA[removed][removed]FAX: ([removed]August 28, 2006 Add to Reading List Source URL: www.gene.com Language: English - Date: 2014-03-31 07:24:10 Ranibizumab Bevacizumab Vascular endothelial growth factor Genentech Retinopathy of prematurity Macular degeneration MedWatch Food and Drug Administration Endophthalmitis Medicine Health Pharmacology
353	Genentech Sustainability Data and Notes[removed]Performance Data Units 2007 Add to Reading List Source URL: www.gene.com Language: English - Date: 2014-03-31 07:24:03 Air dispersion modeling Chemical engineering Emission intensity Environmental engineering Emissions & Generation Resource Integrated Database AP 42 Compilation of Air Pollutant Emission Factors Greenhouse gas California Air Resources Board City of Oakland Energy and Climate Action Plan Air pollution Atmosphere Pollution
354	1 DNA Way South San Francisco, CA[removed]May 13, 2013 Important Drug Information KADCYLA™ (ado-trastuzumab emtansine) 100 mg (NDC[removed]) Add to Reading List Source URL: www.gene.com Language: English - Date: 2014-03-31 07:24:10 Mertansine HER2/neu Biologic Pharmacology Medicine Trastuzumab Genentech Biology
355	1 DNA Way South San Francisco, CA[removed][removed]FAX: ([removed]December 19, 2008 Add to Reading List Source URL: www.gene.com Language: English - Date: 2014-03-31 07:24:11 Bevacizumab Genentech Food and Drug Administration MedWatch Off-label use Patient safety Colorectal cancer Presumed ocular histoplasmosis syndrome Medicine Health Pharmacology
356	IMPORTANT DRUG WARNING[removed]Higher incidence of new cases of ovarian failure observed in premenopausal women treated with Avastin® (bevacizumab) Dear Healthcare Provider: Add to Reading List Source URL: www.gene.com Language: English - Date: 2014-03-31 07:24:10 Menstrual cycle Ovarian cancer Colorectal cancer Vascular endothelial growth factor Renal cell carcinoma Menopause Presumed ocular histoplasmosis syndrome Medicine Bevacizumab Genentech
357	August[removed]IMPORTANT DRUG WARNING Dear Healthcare Provider: Genentech, Inc. wishes to inform you of updated cardiotoxicity information related to the use of HERCEPTIN® (trastuzumab), obtained from the National Surgica Add to Reading List Source URL: www.gene.com Language: English - Date: 2014-03-31 07:24:11 Cancer treatments Breast cancer Ribbon symbolism Chemotherapy regimens Trastuzumab HER2/neu Adjuvant therapy Metastatic breast cancer Radionuclide angiography Medicine Oncology Chemistry
358	IMPORTANT DRUG WARNING SUBJECT: Fatal Embryo-Fetal Toxicity due to Herceptin Exposure During Pregnancy Dear U.S. Healthcare Professional: Genentech, Inc. would like to inform you of important new safety information regar Add to Reading List Source URL: www.gene.com Language: English - Date: 2014-03-31 07:24:11 Ribbon symbolism Breast cancer Trastuzumab Oligohydramnios Breast cancer treatment HER2/neu Genentech Management of cancer Pulmonary hypoplasia Medicine Oncology Cancer treatments
359	IMPORTANT DRUG WARNING 1 DNA Way South San Francisco, CA 94080 Add to Reading List Source URL: www.gene.com Language: English - Date: 2014-03-31 07:24:13 Bevacizumab Necrotizing fasciitis Genentech Adverse effect Food and Drug Administration Colorectal cancer Presumed ocular histoplasmosis syndrome Medicine Health Pharmacology
360	Avastin vs Lucentis Letter sent to Vice-President Almunia on November 7th, 2013 Contact: Ilaria Passarani – [removed] Ref.: BEUC-X[removed]/2014 Add to Reading List Source URL: www.beuc.eu Language: English - Date: 2014-03-05 04:20:37 Health Genentech Macular degeneration Ranibizumab Novartis Hoffmann-La Roche Off-label use Presumed ocular histoplasmosis syndrome Medicine Pharmacology Bevacizumab

UPDATE